Skylands Capital, LLC Cytosorbents Corp Transaction History

Skylands Capital, LLC

$688 Million
Q1 2024

A detailed history of Skylands Capital, LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Skylands Capital, LLC holds 2,875,552 shares of CTSO stock, worth $2.47 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

2,875,552

Previous 3,254,213 11.64%

Holding current value

$2.47 Million

Previous $3.61 Million 24.39%

% of portfolio

0.4%

Previous 0.55%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$0.86 - $1.07 $325,648 - $405,167	-378,661 Reduced 11.64%	2,875,552 $2.73 Million
Q4 2023 Feb 05, 2024	BUY	$1.08 - $1.94 $334,306 - $600,513	309,543 Added 10.51%	3,254,213 $3.61 Million
Q3 2023 Oct 27, 2023	BUY	$1.86 - $4.03 $281,232 - $609,336	151,200 Added 5.41%	2,944,670 $5.54 Million
Q2 2023 Aug 03, 2023	BUY	$2.37 - $3.65 $91,245 - $140,525	38,500 Added 1.4%	2,793,470 $10 Million
Q1 2023 May 04, 2023	BUY	$1.79 - $4.17 $381,053 - $887,705	212,879 Added 8.37%	2,754,970 $9.28 Million

Q4 2022 Feb 09, 2023	BUY	$1.03 - $1.63 $200,908 - $317,942	195,057 Added 8.31%	2,542,091 $3.94 Million
Q3 2022 Nov 01, 2022	BUY	$1.39 - $2.46 $30,631 - $54,211	22,037 Added 0.95%	2,347,034 $3.19 Million
Q2 2022 Jul 28, 2022	BUY	$1.76 - $3.22 $346,799 - $634,484	197,045 Added 9.26%	2,324,997 $5.09 Million
Q1 2022 May 05, 2022	BUY	$2.88 - $4.23 $522,944 - $768,074	181,578 Added 9.33%	2,127,952 $6.79 Million
Q4 2021 Feb 08, 2022	BUY	$4.05 - $8.11 $440,773 - $882,635	108,833 Added 5.92%	1,946,374 $8.16 Million
Q3 2021 Nov 02, 2021	BUY	$7.0 - $9.71 $458,787 - $636,403	65,541 Added 3.7%	1,837,541 $14.9 Million
Q2 2021 Aug 02, 2021	BUY	$7.55 - $9.42 $1.47 Million - $1.84 Million	194,800 Added 12.35%	1,772,000 $13.4 Million
Q1 2021 May 04, 2021	BUY	$8.23 - $11.48 $409,854 - $571,704	49,800 Added 3.26%	1,577,200 $13.7 Million
Q4 2020 Feb 09, 2021	BUY	$7.65 - $8.98 $808,605 - $949,186	105,700 Added 7.43%	1,527,400 $12.2 Million
Q3 2020 Oct 27, 2020	BUY	$7.37 - $11.54 $1.69 Million - $2.64 Million	228,900 Added 19.19%	1,421,700 $11.3 Million
Q2 2020 Jul 29, 2020	BUY	$6.28 - $10.59 $417,620 - $704,235	66,500 Added 5.9%	1,192,800 $11.8 Million
Q1 2020 Apr 27, 2020	BUY	$3.77 - $7.73 $1.17 Million - $2.4 Million	310,431 Added 38.05%	1,126,300 $8.71 Million
Q4 2019 Feb 11, 2020	BUY	$3.61 - $5.22 $150,244 - $217,251	41,619 Added 5.38%	815,869 $3.14 Million
Q3 2019 Oct 29, 2019	BUY	$4.33 - $7.63 $405,504 - $714,549	93,650 Added 13.76%	774,250 $3.89 Million
Q2 2019 Jul 29, 2019	BUY	$5.92 - $7.78 $263,736 - $346,599	44,550 Added 7.0%	680,600 $4.5 Million
Q1 2019 Apr 30, 2019	BUY	$6.82 - $8.56 $956,164 - $1.2 Million	140,200 Added 28.27%	636,050 $4.82 Million
Q4 2018 Feb 07, 2019	BUY	$7.05 - $12.64 $266,490 - $477,792	37,800 Added 8.25%	495,850 $4.01 Million
Q3 2018 Oct 22, 2018	SELL	$10.95 - $14.8 $421,575 - $569,800	-38,500 Reduced 7.75%	458,050 $5.91 Million
Q2 2018 Jul 24, 2018	SELL	$6.9 - $12.35 $1.31 Million - $2.35 Million	-190,400 Reduced 27.72%	496,550 $5.66 Million
Q1 2018 Apr 19, 2018	SELL	$6.55 - $8.2 $253,209 - $316,995	-38,658 Reduced 5.33%	686,950 $4.84 Million
Q4 2017 Jan 16, 2018	BUY	$5.9 - $7.05 $1.33 Million - $1.59 Million	225,558 Added 45.11%	725,608 $4.72 Million
Q3 2017 Oct 19, 2017	BUY	$4.5 - $6.2 $2.25 Million - $3.1 Million	500,050	500,050 $3.1 Million

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skylands Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skylands Capital, LLC with notifications on news.

Account

Skylands Capital, LLC Cytosorbents Corp Transaction History